LexDanaLexDanabeta
Inventor

ADRIANNA LATUSZEK

Inventor
US

Overview

3→
Patents
2021–2022
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A01KAnimal husbandry9%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
11,492,392Polynucleotides encoding anti-C5 antibodies202211,479,602Methods of treating C5-associated diseases comprising administering anti-C5 antibodies202211,178,860Humanized C5 animals2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2022Patents assigned to REGENERON PHARMA (3)· patent assignee history
2021–2022Based in US· patent location history
2022Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2022Patents assigned to REGENEREN PHARMACEUTICALS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REGENERON PHARMA32021–2022
REGENERAN PHARMACEUTICALS INC12022
REGENEREN PHARMACEUTICALS INC12022
Locations
LocationPatentsSpan
US32021–2022